CD47 and neoplasm: Possible strategies to improve exosome biodistribution include surface modification with PEG or CD47 to reduce macrophage uptake [265], incorporation of tumor-homing peptides (iRGD) [225], magnetic guidance using iron oxide nanoparticles [284], or locoregional administration (intratumoral, intraperitoneal) to bypass systemic clearance [285].